ConductScience.org, home

Paper3115643

Anti-pseudomonas activity of anti-lipopolysaccharide hyperimmune equine plasma.

Wells M and 1 other. Clin Exp Immunol, 1987. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Anti-pseudomonas activity of anti-lipopolysaccharide hyperimmune equine plasma. Papers, record 3115643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3115643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-pseudomonas activity of anti-lipopolysaccharide hyperimmune equine plasma.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.18
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wells MM
2Gaffin SLS L

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunization, PassiveMajor topic
LipopolysaccharidesMajor topic
PseudomonasMajor topic
Animals
Blood Bactericidal Activity
Horses
Immunoglobulin G
Limulus Test
Pseudomonas aeruginosa

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16140518Large-scale production of anti-gram-negative bacterial antibodies.Lancet1983https://conductscience.org/library/papers/6140518PubMed
26668580The use of equine anti-endotoxin hyperimmune serum in the treatment of septic arthritis in foals.J S Afr Vet Assoc1983https://conductscience.org/library/papers/6668580PubMed
36143965Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin.Lancet1984https://conductscience.org/library/papers/6143965PubMed
46384378Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.J Infect Dis1984https://conductscience.org/library/papers/6384378PubMed
56148609Anti-lipopolysaccharide antibodies: update.Lancet1984https://conductscience.org/library/papers/6148609PubMed
66437435Topical immunotherapy for pseudomonas keratitis in rabbits: use of antilipopolysaccharide plasma.Br J Ophthalmol1984https://conductscience.org/library/papers/6437435PubMed
76501933Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay.J Infect Dis1984https://conductscience.org/library/papers/6501933PubMed
83922117Properties of human anti-lipopolysaccharide gamma globulin: specificity and protective effects.Vox Sang1985https://conductscience.org/library/papers/3922117PubMed
92865475Opsonisation of gram-negative bacteria by anti-lipopolysaccharide antibodies.Lancet1985https://conductscience.org/library/papers/2865475PubMed
103916066Anti-lipopolysaccharide toxin therapy for whole body X-irradiation overdose.Br J Radiol1985https://conductscience.org/library/papers/3916066PubMed
114978929Induction of spheroplasts of Pseudomonas aeruginosa by carbenicillin.Appl Microbiol1969https://conductscience.org/library/papers/4978929PubMed
124621762Septic complications of war wounds.JAMA1972https://conductscience.org/library/papers/4621762PubMed
134622186The requirement for serum complement in the detoxification of bacterial endotoxin.J Immunol1972https://conductscience.org/library/papers/4622186PubMed
141094313Endotoxin and acute renal failure.Nephron1975https://conductscience.org/library/papers/1094313PubMed
151140855Opsonizing antibodies, host factors, and the limulus assay for endotoxin.Infect Immun1975https://conductscience.org/library/papers/1140855PubMed
1670173Isolation from human serum of an inactivator of bacterial lipopolysaccharide.Am J Pathol1977https://conductscience.org/library/papers/70173PubMed
17409788Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.J Infect Dis1977https://conductscience.org/library/papers/409788PubMed
18375173Standard and special human immune serum globulins as therapeutic agents.Pediatrics1979https://conductscience.org/library/papers/375173PubMed
196986406Comparison of plasma extraction techniques in preparation of samples for endotoxin testing by the Limulus amoebocyte lysate test.J Clin Microbiol1980https://conductscience.org/library/papers/6986406PubMed
206108445Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.Lancet1980https://conductscience.org/library/papers/6108445PubMed

See all 27 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3115643

GET https://conductscience.org/api/papers/v1/3115643/references?page=2